Vaccines A-Z

Precision Vaccinations

 / April 19th, 2024

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Apr 18 • 5:20 pm CDT
While measles outbreaks have been reported in dozens of countries in 2024, recent attention has focused on the cities of Chicago and London. The U.K. Health Security Agency (UKHSA) published an updated epidemiological overview on April... READ →
Apr 18 • 11:22 am CDT
GSK plc today announced positive data from a long-term follow-up phase III clinical trial. The trial followed participants up to approximately 11 years following initial vaccination with Shingrix®, a non-live, recombinant subunit Herpes Zoster vaccine. Announced... READ →
Apr 18 • 9:30 am CDT
According to Quebec's National Institute of Excellence in Health and Social Services (INESSS), there will be an increasing demand for emergency services in 2024, which shows the need for all infants to be protected from Respiratory... READ →
Apr 17 • 3:25 pm CDT
GSK today announced positive results from the pivotal phase III trial for gepotidacin, a potential first-in-class oral antibiotic with a novel mechanism of action for uncomplicated urogenital gonorrhea in adolescents and adults. The study's results showed... READ →
Apr 17 • 1:18 pm CDT
A vaccine to prevent chlamydia infections is considered an important measure to control sexually transmitted and ocular infections. Chlamydia trachomatis is the most common sexually transmitted bacterial infection worldwide, says the U.S. CDC. As of April... READ →

For more articles, try our search.